« previous next »
Pages: [1]   Go Down

Author Topic: New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options  (Read 37 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 694
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options
« on: November 05, 2024, 07:42:12 PM »
New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options

Orlynvah, an oral tablet from drug manufacturer Iterum Therapeutics, combining sulopenem etzadroxil and probenecid has been approved for use specifically for treating uncomplicated urinary tract infections (UTIs) in adult women.
Source: New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options
« on: November 05, 2024, 07:42:12 PM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal